Ardent Health (NYSE:ARDT) Stock Price Up 3.9% – Here’s Why

Shares of Ardent Health, Inc. (NYSE:ARDT) shot up 3.9% during mid-day trading on Tuesday . The company traded as high as $11.14 and last traded at $11.2450. 29,026 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 448,545 shares. The stock had previously closed at $10.82.

Analysts Set New Price Targets

ARDT has been the subject of several recent research reports. Weiss Ratings downgraded Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Zacks Research cut Ardent Health from a “hold” rating to a “strong sell” rating in a research report on Thursday, August 6th. Guggenheim boosted their target price on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. UBS Group upped their target price on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Royal Bank Of Canada raised their price target on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $13.05.

Ardent Health Stock Performance

The firm has a market cap of $1.54 billion, a PE ratio of 19.80, a P/E/G ratio of 3.06 and a beta of 0.71. The stock has a 50-day moving average price of $10.65 and a 200 day moving average price of $9.80. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99.

Ardent Health (NYSE:ARDT) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.06). The business had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Research analysts forecast that Ardent Health, Inc. will post 0.97 earnings per share for the current year.

Insider Transactions at Ardent Health

In related news, CFO Alfred Lumsdaine bought 10,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.90% of the company’s stock.

Hedge Funds Weigh In On Ardent Health

A number of hedge funds have recently made changes to their positions in ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Ardent Health by 103.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after buying an additional 7,182 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after acquiring an additional 724,841 shares during the last quarter. Jane Street Group LLC grew its position in Ardent Health by 235.1% during the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after acquiring an additional 40,318 shares during the period. Acadian Asset Management LLC grew its position in Ardent Health by 574.9% during the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after acquiring an additional 34,276 shares during the period. Finally, Geode Capital Management LLC increased its stake in Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after acquiring an additional 1,769 shares during the last quarter.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.